Unexplained weight loss (UWL) is a diagnostic challenge in clinical practice. It is a potential indicator of serious underlying disease, often signaling malignancy, gastrointestinal disorders, or endocrine abnormalities. A systematic and comprehensive approach is essential to identify the cause and initiate appropriate management.
The initial evaluation of UWL should involve a detailed history and thorough physical examination. Clinicians should inquire about changes in appetite, dietary intake, and physical activity. History of associated symptoms, medication use, and psychosocial factors should also be considered. Physical examination can provide clues to systemic diseases such as malignancies or chronic infections.
Initial laboratory investigations should include complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers. Imaging studies, such as chest radiographs and abdominal ultrasound, may be helpful based on the patient's symptoms and risk factors. Further diagnostic tests should be guided by initial findings and clinical suspicion.
In elderly patients, UWL may be the only manifestation of a serious disease. Therefore, a high index of suspicion is required. In patients with psychiatric history, disorders such as depression and eating disorders should be considered. In cases where no clear cause is identified despite extensive evaluation, a diagnosis of idiopathic UWL may be considered, and close follow-up is recommended.
Unexplained weight loss is a common but challenging clinical scenario. It requires a systematic and comprehensive approach to evaluation, including detailed history, physical examination, and judicious use of laboratory and imaging studies. Special considerations are needed for elderly patients and those with psychiatric history. Clinicians should maintain a high index of suspicion for serious underlying diseases and ensure close follow-up for patients with idiopathic UWL.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation